Endocannabinoids render exploratory behaviour largely independent of the test aversiveness: Role of glutamatergic transmission

Genes, Brain and Behavior

Volumn 8, Issue 7, 2009, Pages 685-698

  Jacob, W ^a   Yassouridis, A ^a   Marsicano, G ^b   Monory, K ^c   Lutz, B ^c   Wotjak, C T ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b INSTITUT FRANÇOIS MAGENDIE   (France)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Anxiety; CB1; Endocannabinoids; Exploration; Fear; Glutamate; Habituation; Mice

Indexed keywords

CANNABINOID 1 RECEPTOR; ENDOCANNABINOID; GLUTAMIC ACID;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; AVERSIVE BEHAVIOR; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; EMOTION; EXPLORATORY BEHAVIOR; GENOTYPE; IMMOBILIZATION; LIGHT INTENSITY; LOCOMOTION; MALE; MAZE TEST; MOUSE; NEUROTRANSMISSION; NONHUMAN; OPEN FIELD BEHAVIOR; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REARING; SOCIAL BEHAVIOR;

ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; BRAIN CHEMISTRY; CEREBRAL CORTEX; ENDOCANNABINOIDS; EXPLORATORY BEHAVIOR; FEAR; GLUTAMIC ACID; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUROPSYCHOLOGICAL TESTS; PHENOTYPE; PHOTOPHOBIA; RECEPTOR, CANNABINOID, CB1; SYNAPTIC TRANSMISSION;

ANIMALIA; MUS;

EID: 70349685317     PISSN: 16011848     EISSN: 1601183X     Source Type: Journal    
DOI: 10.1111/j.1601-183X.2009.00512.x     Document Type: Article

References (62)

1. Bambico, F.R., Katz, N., Debonnel, G. & Gobbi, G. (2007) Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex. J Neurosci 27, 11700 11711.
2. Blanchard, R.J. & Blanchard, D.C. (1989) Antipredator defensive behaviors in a visible burrow system. J.Comp Psychol 103, 70 82.
3. Blanchard, D.C., Griebel, G. & Blanchard, R.J. (2001) Mouse defensive behaviors: pharmacological and behavioral assays for anxiety and panic. Neurosci Biobehav Rev 25, 205 218.
4. Carobrez, A.P. & Bertoglio, L.J. (2005) Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Neurosci Biobehav Rev 29, 1193 1205.
5. Degroot, A. & Nomikos, G.G. (2004) Genetic deletion and pharmacological blockade of CB1 receptors modulates anxiety in the shock-probe burying test. Eur J Neurosci 20, 1059 1064.
6. Degroot, A., Salhoff, C., Davis, R.J. & Nomikos, G.G. (2005) Genetic deletion of CB1 receptors improves non-associative learning. Behav Brain Res 162, 161 164.
7. Di, S., Malcher-Lopes, R., Halmos, K.C. & Tasker, J.G. (2003) Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. J.Neurosci 23, 4850 4857.
8. Hascoet, M., Bourin, M. & Dhonnchadha, B.A. (2001) The mouse light-dark paradigm: a review. Prog Neuropsychopharmacol Biol Psychiatry 25, 141 166.
9. File, S.E. & Zangrossi, H. Jr. (1993) "One-trial tolerance" to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state? Psychopharmacology (Berl) 110, 240 244.
10. File, S.E., Zangrossi, H. Jr., Viana, M. & Graeff, F.G. (1993) Trial 2 in the elevated plus-maze: a different form of fear? Psychopharmacology (Berl) 111, 491 494.
11. File, S.E., Gonzalez, L.E. & Andrews, N. (1996) Comparative study of pre- and postsynaptic 5-HT1A receptor modulation of anxiety in two ethological animal tests. J Neurosci 16, 4810 4815.
12. File, S.E. & Seth, P. (2003) A review of 25 years of the social interaction test. Eur J Pharmacol 463, 35 53.
13. Gobbi, G., Bambico, F.R., Mangieri, R., Bortolato, M., Campolongo, P., Solinas, M., Cassano, T., Morgese, M.G., Debonnel, G., Duranti, A., Tontini, A., Tarzia, G., Mor, M., Trezza, V., Goldberg, S.R., Cuomo, V. & Piomelli, D. (2005) Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc Natl Acad Sci U S A 102, 18620 18625.
14. Gonzalez, L.E. & File, S.E. (1997) A five minute experience in the elevated plus-maze alters the state of the benzodiazepine receptor in the dorsal raphe nucleus. J Neurosci 17, 1505 1511.
15. Griebel, G. (1995) 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research. Pharmacol Ther 65, 319 395.
16. Haller, J., Bakos, N., Szirmay, M., Ledent, C. & Freund, T.F. (2002) The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety. Eur J Neurosci 16, 1395 1398.
17. Haller, J., Varga, B., Ledent, C., Barna, I. & Freund, T.F. (2004) Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice. Eur J Neurosci 19, 1906 1912.
18. Haller, J., Matyas, F., Soproni, K., Varga, B., Barsy, B., Nemeth, B., Mikics, E., Freund, T.F. & Hajos, N. (2007) Correlated species differences in the effects of cannabinoid ligands on anxiety and on GABAergic and glutamatergic synaptic transmission. Eur J Neurosci 25, 2445 2456.
19. Haller, J., Barna, I., Barsvari, B., Gyimesi, P.K., Yasar, S., Panlilio, L.V. & Goldberg, S. (2009) Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats. Psychopharmacology (Berl.) 204, 607 616.
20. Haring, M., Marsicano, G., Lutz, B. & Monory, K. (2007) Identification of the cannabinoid receptor type 1 in serotonergic cells of raphe nuclei in mice. Neuroscience 146, 1212 1219.
21. Holmes, A. & Rodgers, R.J. (1999) Influence of spatial and temporal manipulations on the anxiolytic efficacy of chlordiazepoxide in mice previously exposed to the elevated plus-maze. Neurosci Biobehav Rev 23, 971 980.
22. Kalueff, A.V., Fox, M.A., Gallagher, P.S. & Murphy, D.L. (2007) Hypolocomotion, anxiety and serotonin syndrome-like behavior contribute to the complex phenotype of serotonin transporter knockout mice. Genes Brain Behav 6, 389 400.
23. Kamprath, K., Marsicano, G., Tang, J., Monory, K., Bisogno, T., Di Marzo, V., Lutz, B. & Wotjak, C.T. (2006) Cannabinoid CB1 receptor mediates fear extinction via habituation-like processes. J Neurosci 26, 6677 6686.
24. Kamprath, K., Plendl, W., Marsicano, G., Deussing, J.M., Wurst, W., Lutz, B. & Wotjak, C.T. (2009) Endocannabinoids mediate fear adaptation via glutamatergic neurons independently of corticotropin-releasing hormone signaling. Genes Brain Behav 8, 203 211.
25. Katona, I., Urban, G.M., Wallace, M., Ledent, C., Jung, K.M., Piomelli, D., MacKie, K. & Freund, T.F. (2006) Molecular composition of the endocannabinoid system at glutamatergic synapses. J Neurosci 26, 5628 5637.
26. Kawamura, Y., Fukaya, M., Maejima, T., Yoshida, T., Miura, E., Watanabe, M., Ohno-Shosaku, T. & Kano, M. (2006) The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum. J Neurosci 26, 2991 3001.
27. Kromer, S.A., Kessler, M.S., Milfay, D., Birg, I.N., Bunck, M., Czibere, L., Panhuysen, M., Putz, B., Deussing, J.M., Holsboer, F., Landgraf, R. & Turck, C.W. (2005) Identification of glyoxalase-I as a protein marker in a mouse model of extremes in trait anxiety. J Neurosci 25, 4375 4384.
28. Levine, E.S. & Jacobs, B.L. (1992) Neurochemical afferents controlling the activity of serotonergic neurons in the dorsal raphe nucleus: microiontophoretic studies in the awake cat. J Neurosci 12, 4037 4044.
29. Maccarrone, M., Valverde, O., Barbaccia, M.L., Castane, A., Maldonado, R., Ledent, C., Parmentier, M. & Finazzi-Agro, A. (2002) Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour. Eur J Neurosci 15, 1178 1186.
30. Marsicano, G. & Lutz, B. (1999) Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur J Neurosci 11, 4213 4225.
31. Marsicano, G., Wotjak, C.T., Azad, S.C., Bisogno, T., Rammes, G., Cascio, M.G., Hermann, H., Tang, J., Hofmann, C., Zieglgansberger, W., Di Marzo, V. & Lutz, B. (2002) The endogenous cannabinoid system controls extinction of aversive memories. Nature 418, 530 534.
32. Marsicano, G., Goodenough, S., Monory, K., Hermann, H., Eder, M., Cannich, A., Azad, S.C., Cascio, M.G., Gutierrez, S.O., van der, S.M., Lopez-Rodriguez, M.L., Casanova, E., Schutz, G., Zieglgansberger, W., Di Marzo, V., Behl, C. & Lutz, B. (2003) CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302, 84 88.
33. Martin, M., Ledent, C., Parmentier, M., Maldonado, R. & Valverde, O. (2002) Involvement of CB1 cannabinoid receptors in emotional behaviour. Psychopharmacology (Berl) 159, 379 387.
34. McNaughton, N. & Corr, P.J. (2004) A two-dimensional neuropsychology of defense: fear/anxiety and defensive distance. Neurosci Biobehav Rev 28, 285 305.
35. Millan, M.J. (2003) The neurobiology and control of anxious states. Prog Neurobiol 70, 83 244.
36. Milner, L.C. & Crabbe, J.C. (2008) Three murine anxiety models: results from multiple inbred strain comparisons. Genes Brain Behav 7, 496 505.
37. Monory, K., Massa, F., Egertova, M. et al. (2006) The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron 51, 455 466.
38. Monory, K., Blaudzun, H., Massa, F., Kaiser, N., Lemberger, T., Schutz, G., Wotjak, C.T., Lutz, B. & Marsicano, G. (2007) Genetic dissection of behavioural and autonomic effects of delta(9)-tetrahydrocannabinol in mice. PLoS Biol 5, e269.
39. Moreira, F.A., Kaiser, N., Monory, K. & Lutz, B. (2008) Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors. Neuropharmacology 54, 141 150.
40. Muller, M.B., Zimmermann, S., Sillaber, I., Hagemeyer, T.P., Deussing, J.M., Timpl, P., Kormann, M.S., Droste, S.K., Kuhn, R., Reul, J.M., Holsboer, F. & Wurst, W. (2003) Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress. Nat Neurosci 6, 1100 1107.
41. Naidu, P.S., Varvel, S.A., Ahn, K., Cravatt, B.F., Martin, B.R. & Lichtman, A.H. (2007) Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality. Psychopharmacology (Berl.) 192, 61 70.
42. Patel, S., Roelke, C.T., Rademacher, D.J. & Hillard, C.J. (2005) Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signalling. Eur J Neurosci 21, 1057 1069.
43. Patel, S. & Hillard, C.J. (2006) Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling. J Pharmacol Exp Ther 318, 304 311.
44. Patel, S. & Hillard, C.J. (2008) Adaptations in endocannabinoid signaling in response to repeated homotypic stress: a novel mechanism for stress habituation. Eur J Neurosci 27, 2821 2829.
45. Ressler, K.J. & Nemeroff, C.B. (2000) Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety 12 (Suppl. 1 2 19.
46. Riedel, G. & Davies, S.N. (2005) Cannabinoid function in learning, memory and plasticity. Handb Exp Pharmacol 168, 445 477.
47. Rodgers, R.J. & Dalvi, A. (1997) Anxiety, defence and the elevated plus-maze. Neurosci Biobehav Rev 21, 801 810.
48. Rodgers, R.J., Haller, J., Holmes, A., Halasz, J., Walton, T.J. & Brain, P.F. (1999) Corticosterone response to the plus-maze: high correlation with risk assessment in rats and mice. Physiol Behav 68, 47 53.
49. Rodgers, R.J., Haller, J., Halasz, J. & Mikics, E. (2003) 'One-trial sensitization' to the anxiolytic-like effects of cannabinoid receptor antagonist SR141716A in the mouse elevated plus-maze. Eur J Neurosci 17, 1279 1286.
50. Rodgers, R.J., Evans, P.M. & Murphy, A. (2005) Anxiogenic profile of AM-251, a selective cannabinoid CB1 receptor antagonist, in plus-maze-naive and plus-maze-experienced mice. Behav Pharmacol 16, 405 413.
51. Singewald, N. (2007) Altered brain activity processing in high-anxiety rodents revealed by challenge paradigms and functional mapping. Neurosci Biobehav Rev 31, 18 40.
52. Steiner, M.A., Marsicano, G., Wotjak, C.T. & Lutz, B. (2008) Conditional cannabinoid receptor type 1 mutants reveal neuron subpopulation-specific effects on behavioral and neuroendocrine stress responses. Psychoneuroendocrinology 33, 1165 1170.
53. Takahashi, K.A. & Castillo, P.E. (2006) The CB1 cannabinoid receptor mediates glutamatergic synaptic suppression in the hippocampus. Neuroscience 139, 795 802.
54. Tao, R. & Auerbach, S.B. (2003) Influence of inhibitory and excitatory inputs on serotonin efflux differs in the dorsal and median raphe nuclei. Brain Res 961, 109 120.
55. Thiemann, G., Fletcher, B.C., Ledent, C., Molleman, A. & Hasenohrl, R.U. (2007) The genetic versus pharmacological invalidation of the cannabinoid CB(1) receptor results in differential effects on 'non-associative' memory and forebrain monoamine concentrations in mice. Neurobiol Learn Mem 88, 416 423.
56. Thiemann, G., Watt, C.A., Ledent, C., Molleman, A. & Hasenohrl, R.U. (2009) Modulation of anxiety by acute blockade and genetic deletion of the CB(1) cannabinoid receptor in mice together with biogenic amine changes in the forebrain. Behav Brain Res 200, 60 67.
57. Thoeringer, C.K., Sillaber, I., Roedel, A., Erhardt, A., Mueller, M.B., Ohl, F., Holsboer, F. & Keck, M.E. (2007) The temporal dynamics of intrahippocampal corticosterone in response to stress-related stimuli with different emotional and physical load: an in vivo microdialysis study in C57BL/6 and DBA/2 inbred mice. Psychoneuroendocrinology 32, 746 757.
58. Timpl, P., Spanagel, R., Sillaber, I., Kresse, A., Reul, J.M., Stalla, G.K., Blanquet, V., Steckler, T., Holsboer, F. & Wurst, W. (1998) Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat Genet 19, 162 166. (Pubitemid 28248798)
59. Touma, C., Bunck, M., Glasl, L., Nussbaumer, M., Palme, R., Stein, H., Wolferstatter, M., Zeh, R., Zimbelmann, M., Holsboer, F. & Landgraf, R. (2008) Mice selected for high versus low stress reactivity: a new animal model for affective disorders. Psychoneuroendocrinology 33, 839 862.
60. Uriguen, L., Perez-Rial, S., Ledent, C., Palomo, T. & Manzanares, J. (2004) Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors. Neuropharmacology 46, 966 973.
61. Varma, N., Carlson, G.C., Ledent, C. & Alger, B.E. (2001) Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus. J Neurosci 21, RC188.
62. Wolfer, D.P., Litvin, O., Morf, S., Nitsch, R.M., Lipp, H.P. & Wurbel, H. (2004) Laboratory animal welfare: cage enrichment and mouse behaviour. Nature 432, 821 822.